Sort
141,003 grants matching “cytokine”
Nuclear Factor-kappaB in Ovarian Cancer
$828,564Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Immune Correlates of Protection from TB
$828,491Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2017 · AI
Transcriptional control in the macrophage response to pathogens
$828,448Alan A Aderem · University Of Washington · U54 · FY2008 · AI
AirPressureNYC: Reducing AIR pollution to lower blood PRESSURE among New York City public housing residents
$828,434Jonathan D Newman · New York University School Of Medicine · R01 · FY2024 · HL
The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance
$828,127John Koethe · Vanderbilt University Medical Center · R01 · FY2019 · DK
Pathophysiology of Renal Allograft Dysfunction
$828,097Duke University · P01 · FY2005 · DK
The Risk of Myocardial Infarction in Patients with Psoriasis
$828,093Joel M Gelfand · University Of Pennsylvania · R01 · FY2010 · HL
CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity
$828,044David Tuveson · Cold Spring Harbor Laboratory · U01 · FY2019 · CA
Notch Mediated Expansion of Hematopoietic Precursors
$827,992Fred Hutchinson Cancer Research Center · R24 · FY2004 · HL
TL1A and its receptor DR3 in normal and autoimmune T cell responses
$827,944Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
Antibody Responses in Aging SIV Infected Monkeys
$827,888Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2015 · AI
TOLERANCE TO COMPOSITE ISLET-KIDNEY TRANSPLANTS IN BABOONS
$827,879David H Sachs · Massachusetts General Hospital · U01 · FY2009 · DK
B cell determinants of EBV latency
$827,799Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · CA
A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
$827,713Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2025 · AI
Impact of smoking and its cessation on systemic and airway immune activation
$827,665Nina H. Lin · Boston Medical Center · R01 · FY2016 · DA
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV
$827,657Priscilla Y. Hsue · University Of California, San Francisco · R56 · FY2014 · HL
Computational Immunobiology Core
$827,611Allan D. Kirk · Duke University · U19 · FY2023 · AI
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
$827,515Craig R Cohen · University Of California, San Francisco · R01 · FY2022 · HD
Translating cellular immunotherapies for autoimmunity to canine clinical trials
$827,495Aimee S Payne · University Of Pennsylvania · R01 · FY2022 · AR
Translating cellular immunotherapies for autoimmunity to canine clinical trials
$827,495Aimee S Payne · University Of Pennsylvania · R01 · FY2021 · AR
MyPART: My Pediatric and Adult Rare Tumor Network - Cures
$827,438Brigitte Widemann · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$827,328Afamefuna Okoye · Oregon Health & Science University · R01 · FY2024 · AI
Towards a Vaccine to Prevent Toxoplasmosis
$827,305Rima L McLeod · University Of Chicago · U01 · FY2011 · AI
Imaging Histone Deacetylase in the Heart and Bone Marrow
$827,290David E Sosnovik · Massachusetts General Hospital · R01 · FY2018 · HL
B cell determinants of EBV latency
$827,278Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2024 · CA